DCE-MRI and IVIM-MRI of rabbit Vx2 tumors treated with MR-HIFU-induced mild hyperthermia

Journal of Therapeutic Ultrasound

Volumn 4, Issue 1, 2016, Pages

  Lam, Mie K ^a   Oerlemans, Chris ^a   Froeling, Martijn ^a   Deckers, Roel ^a   Rijbroek, Angelique D Barten Van ^a   Viergever, Max A ^a   W Moonen, Chrit T ^a   Bos, Clemens ^a   Bartels, Lambertus W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Dynamic contrast enhanced MRI; Hyperthermia; Intra voxel incoherent motion MRI; MR HIFU

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING; FEMALE; HIGH INTENSITY FOCUSED ULTRASOUND; HISTOGRAM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPRODUCIBILITY; THERMOTHERAPY; TUMOR VOLUME; VOXEL BASED MORPHOMETRY;

EID: 85010193002     PISSN: None     EISSN: 20505736     Source Type: Journal    
DOI: 10.1186/s40349-016-0052-0     Document Type: Article

References (58)

1. Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet. 1995;345(8949):540-3.
2. Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia. 2001;17(1):1-18.
3. Grull H, Langereis S. Hyperthermia-triggered drug delivery from temperaturesensitive liposomes using MRI-guided high intensity focused ultrasound. J Control Release. 2012;161(2):317-27. doi:10.1016/j.jconrel.2012.04.041.
4. McDaniel JR, Dewhirst MW, Chilkoti A. Actively targeting solid tumours with thermoresponsive drug delivery systems that respond to mild hyperthermia. Int J Hyperthermia. 2013;29(6):501-10. doi:10.3109/02656736.2013.819999.
5. Jain RK. Haemodynamic and transport barriers to the treatment of solid tumours. Int J Radiat Biol. 1991;60(1-2):85-100.
6. Li SP, Padhani AR. Tumor response assessments with diffusion and perfusion MRI. J Magn Reson Imaging. 2012;35(4):745-63. doi:10.1002/jmri.22838.
7. Song CW. Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Res. 1984;44(10 Suppl):4721s-30s.
8. Dudar TE, Jain RK. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res. 1984;44(2):605-12.
9. Gerlowski LE, Jain RK. Effect of hyperthermia on microvascular permeability to macromolecules in normal and tumor tissues. Int J Microcirc Clin Exp. 1985;4(4):363-72.
10. Matsuda H, Sugimachi K, Kuwano H, Mori M. Hyperthermia, tissue microcirculation, and temporarily increased thermosensitivity in VX2 carcinoma in rabbit liver. Cancer Res. 1989;49(10):2777-82.
11. Gnant MF, Noll LA, Terrill RE, Wu PC, Berger AC, Nguyen HQ, et al. Isolated hepatic perfusion for lapine liver metastases: impact of hyperthermia on permeability of tumor neovasculature. Surgery. 1999;126(5):890-9.
12. Kong G, Braun RD, Dewhirst MW. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res. 2001;61(7):3027-32.
13. Li L, ten Hagen TLM, Bolkestein M, Gasselhuber A, Yatvin J, van Rhoon GC, et al. Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia. J Control Release. 2013;167(2):130-7. doi:10.1016/j.jconrel.2013.01.026.
14. Craciunescu OI, Thrall DE, Vujaskovic Z, Dewhirst MW. Magnetic resonance imaging: a potential tool in assessing the addition of hyperthermia to neoadjuvant therapy in patients with locally advanced breast cancer. Int J Hyperthermia. 2010;26(7):625-37. doi:10.3109/02656736.2010.499526.
15. Ludemann L, Wust P, Gellermann J. Perfusion measurement using DCE-MRI: implications for hyperthermia. Int J Hyperthermia. 2008;24(1):91-6. doi:10.1080/02656730701836954.
16. Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med. 1995;33(4):564-8.
17. Sourbron SP, Buckley DL. Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability. Phys Med Biol. 2012;57(2):R1-33. doi:10.1088/0031-9155/57/2/r1.
18. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging. 1997;7(1):91-101.
19. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)- weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10(3):223-32.
20. Zahra MA, Hollingsworth KG, Sala E, Lomas DJ, Tan LT. Dynamic contrastenhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol. 2007;8(1):63-74. doi:10.1016/s1470-2045(06)71012-9.
21. Larsen VA, Simonsen HJ, Law I, Larsson HB, Hansen AE. Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis. Neuroradiology. 2013;55(3):361-9. doi:10.1007/s00234-012-1127-4.
22. Li SP, Makris A, Beresford MJ, Taylor NJ, Ah-See ML, Stirling JJ, et al. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy. Radiology. 2011;260(1):68-78. doi:10.1148/radiol.11102493.
23. Cho N, Im SA, Park IA, Lee KH, Li M, Han W, et al. Breast cancer: early prediction of response to neoadjuvant chemotherapy using parametric response maps for MR imaging. Radiology. 2014;272(2):385-96. doi:10.1148/radiol.14131332.
24. Li X, Arlinghaus LR, Ayers GD, Chakravarthy AB, Abramson RG, Abramson VG, et al. DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings. Magn Reson Med. 2014;71(4):1592-602. doi:10.1002/mrm.24782.
25. Intven M, Reerink O, Philippens ME. Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo-adjuvant chemoradiation. J Magn Reson Imaging. 2014. doi:10.1002/jmri.24718.
26. Zheng D, Chen Y, Liu X, Chen Y, Xu L, Ren W, et al. Early response to chemoradiotherapy for nasopharyngeal carcinoma treatment: value of dynamic contrast-enhanced 3.0 T MRI. J Magn Reson Imaging. 2014. doi:10.1002/jmri.24723.
27. Park JJ, Kim CK, Park SY, Simonetti AW, Kim E, Park BK, et al. Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging. Magn Reson Imaging. 2014;32(8):993-1000. doi:10.1016/j.mri.2014.05.009.
28. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168(2):497-505. doi:10.1148/radiology.168.2.3393671.
29. Henkelman RM. Does IVIM measure classical perfusion Magn Reson Med. 1990;16(3):470-5.
30. Le Bihan D, Turner R. The capillary network: a link between IVIM and classical perfusion. Magn Reson Med. 1992;27(1):171-8.
31. Lemke A, Laun FB, Simon D, Stieltjes B, Schad LR. An in vivo verification of the intravoxel incoherent motion effect in diffusion-weighted imaging of the abdomen. Magn Reson Med. 2010;64(6):1580-5. doi:10.1002/mrm.22565.
32. Luciani A, Vignaud A, Cavet M, Nhieu JT, Mallat A, Ruel L, et al. Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study. Radiology. 2008;249(3):891-9. doi:10.1148/radiol.2493080080.
33. Lemke A, Laun FB, Klauss M, Re TJ, Simon D, Delorme S, et al. Differentiation of pancreas carcinoma from healthy pancreatic tissue using multiple bvalues: comparison of apparent diffusion coefficient and intravoxel incoherent motion derived parameters. Invest Radiol. 2009;44(12):769-75. doi:10.1097/RLI.0b013e3181b62271.
34. Sigmund EE, Cho GY, Kim S, Finn M, Moccaldi M, Jensen JH, et al. Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer. Magn Reson Med. 2011;65(5):1437-47. doi:10.1002/mrm.22740.
35. Sumi M, Van Cauteren M, Sumi T, Obara M, Ichikawa Y, Nakamura T. Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors. Radiology. 2012;263(3):770-7. doi:10.1148/radiol. 12111248.
36. Federau C, O'Brien K, Meuli R, Hagmann P, Maeder P. Measuring brain perfusion with intravoxel incoherent motion (IVIM): initial clinical experience. J Magn Reson Imaging. 2014;39(3):624-32. doi:10.1002/jmri.24195.
37. Gaing B, Sigmund EE, Huang WC, Babb JS, Parikh NS, Stoffel D, et al. Subtype differentiation of renal tumors using voxel-based histogram analysis of intravoxel incoherent motion parameters. Invest Radiol. 2015; 50(3):144-52. doi:10.1097/rli.0000000000000111.
38. Hijnen NM, Heijman E, Kohler MO, Ylihautala M, Ehnholm GJ, Simonetti AW, et al. Tumour hyperthermia and ablation in rats using a clinical MR-HIFU system equipped with a dedicated small animal set-up. Int J Hyperthermia. 2012;28(2):141-55. doi:10.3109/02656736.2011.648137.
39. Staruch R, Chopra R, Hynynen K. Hyperthermia in bone generated with MR imaging-controlled focused ultrasound: control strategies and drug delivery. Radiology. 2012;263(1):117-27. doi:10.1148/radiol.12111189.
40. Ranjan A, Jacobs GC, Woods DL, Negussie AH, Partanen A, Yarmolenko PS, et al. Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model. J Control Release. 2012;158(3):487-94. doi:10.1016/j. jconrel.2011.12.011.
41. de Smet M, Hijnen NM, Langereis S, Elevelt A, Heijman E, Dubois L, et al. Magnetic resonance guided high-intensity focused ultrasound mediated hyperthermia improves the intratumoral distribution of temperaturesensitive liposomal doxorubicin. Invest Radiol. 2013;48(6):395-405. doi:10.1097/RLI.0b013e3182806940.
42. Staruch RM, Hynynen K, Chopra R. Hyperthermia-mediated doxorubicin release from thermosensitive liposomes using MR-HIFU: therapeutic effect in rabbit Vx2 tumours. Int J Hyperthermia. 2015;31(2):118-33. doi:10.3109/ 02656736.2014.992483.
43. Wijlemans JW, Deckers R, van den Bosch MA, Seinstra BA, van Stralen M, van Diest PJ, et al. Evolution of the ablation region after magnetic resonance-guided high-intensity focused ultrasound ablation in a Vx2 tumor model. Invest Radiol. 2013;48(6):381-6. doi:10.1097/RLI. 0b013e3182820257.
44. De Poorter J, De Wagter C, De Deene Y, Thomsen C, Ståhlberg F, Achten E. Noninvasive MRI thermometry with the proton resonance frequency (PRF) method: in vivo results in human muscle. Magn Reson Med. 1995;33:74-81.
45. Ishihara Y, Calderon A, Watanabe H, Okamoto K, Suzuki Y, Kuroda K, et al. A precise and fast temperature mapping using water proton chemical shift. Magn Reson Med. 1995;34:814-23.
46. Vijayakumar S, Huang F, RD E. Improved partial k-space reconstruction technique for dynamic myocardial perfusion MRI. Conf Proc IEEE Eng Med Biol Soc. 2005;2:1419-21. doi:10.1109/iembs.2005.1616696.
47. Kohler MO, Mougenot C, Quesson B, Enholm J, Le Bail B, Laurent C, et al. Volumetric HIFU ablation under 3D guidance of rapid MRI thermometry. Med Phys. 2009;36(8):3521-35.
48. Partanen A, Yarmolenko PS, Viitala A, Appanaboyina S, Haemmerich D, Ranjan A, et al. Mild hyperthermia with magnetic resonance-guided highintensity focused ultrasound for applications in drug delivery. Int J Hyperthermia. 2012;28(4):320-36. doi:10.3109/02656736.2012.680173.
49. Haacke EM, Filleti CL, Gattu R, Ciulla C, Al-Bashir A, Suryanarayanan K, et al. New algorithm for quantifying vascular changes in dynamic contrastenhanced MRI independent of absolute T1 values. Magn Reson Med. 2007;58(3):463-72. doi:10.1002/mrm.21358.
50. Thompson Jr HK, Starmer CF, Whalen RE, McIntosh HD. Indicator transit time considered as a gamma variate. Circ Res. 1964;14:502-15.
51. O'Neill BE, Vo HQ, Shao H, Karmonik C, Zhou X, Li KC. MRI-based prediction of pulsed high-intensity focused ultrasound effect on tissue transport in rabbit muscle. J Magn Reson Imaging. 2013;38(5):1094-102. doi:10.1002/jmri.24087.
52. Orton MR, Collins DJ, Koh DM, Leach MO. Improved intravoxel incoherent motion analysis of diffusion weighted imaging by data driven Bayesian modeling. Magn Reson Med. 2014;71(1):411-20. doi:10.1002/mrm.24649.
53. Zhang YD, Wang Q, Wu CJ, Wang XN, Zhang J, Liu H, et al. The histogram analysis of diffusion-weighted intravoxel incoherent motion (IVIM) imaging for differentiating the Gleason grade of prostate cancer. Eur Radiol. 2015; 25(4):994-1004. doi:10.1007/s00330-014-3511-4.
54. Horsman MR. Tissue physiology and the response to heat. Int J Hyperthermia. 2006;22(3):197-203. doi:10.1080/02656730600689066.
55. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med. 1991;17(2):357-67.
56. Sourbron SP, Buckley DL. On the scope and interpretation of the Tofts models for DCE-MRI. Magn Reson Med. 2011;66(3):735-45. doi:10.1002/mrm.22861.
57. Pekar J, Moonen CTW, van Zijl PCM. On the precision of diffusion/perfusion imaging by gradient sensitization. Magn Reson Med. 1992;23(1):122-9. doi:10.1002/mrm.1910230113.
58. Lam MK, Bos C, Moonen CTW, Viergever MA, Bartels LW. Precision and accuracy of intravoxel incoherent motion (IVIM) MRI: applicability in wellperfused tissues. Milan: International Society for Magnetic Resonance in Medicine 2014.